Preventive treatment with the calcitonin gene-related peptide (CGRP) receptor monoclonal antibody erenumab for 6 weeks was not associated with significant reductions in weekly headache attacks, pain ...

Compared with placebo, eptinezumab failed to significantly reduce the number of episodic cluster headache (ECH) attacks but showed higher responder rates and improved quality-of-life measures. "Among ...

Daylight saving time is famously brutal on the body, disrupting sleep and leaving much of the nation groggy for days ...

Cluster headaches aren't that common, but they are extremely painful. And they often occur during the fall season. A cluster headache is a rare headache disorder that differs from a typical migraine ...

BATON ROUGE, La. (WAFB) - Many welcome the extra hour of sleep that comes with Daylight Saving Time ending, but for some people the time change literally causes headaches. Dr. Tony Johnson with Baton ...

Please provide your email address to receive an email when new articles are posted on . Approximately one in 1,000 people have cluster headaches. Cluster headaches are nicknamed “suicide headaches” ...

Eli Lilly secured federal approval for Emgality, the first migraine treatment approved in the U.S. for decreasing the frequency of episodic cluster headache attacks, the FDA announced June 4. 1.

In a paper published in the May issue of JAMA, M. S. Robbins, of Weill Cornell Medical College, reviews the diagnosis, prevention, and treatment of primary headaches. In a previous post, I discussed ...

Prednisone is a corticosteroid that’s commonly used across a wide range of medical specialties for its anti-inflammatory properties. In neurology, it has emerged as a therapeutic option for the acute ...